Literature DB >> 17361018

A murine scavenger receptor MARCO recognizes polystyrene nanoparticles.

Sanae Kanno1, Akiko Furuyama, Seishiro Hirano.   

Abstract

Recent toxicological studies indicate that nanoparticles or ultrafine particles (< 100 nm) are more toxic than fine particles (< 2 microm) because of their greater surface area. It is well known that alveolar macrophages play an important role in the first defense against various environmental particles and microorganisms. This is accomplished by binding to a macrophage receptor with collagenous structure (MARCO), one of several scavenger-type receptors expressed on the cell surface of macrophages. MARCO has been shown to mediate the ingestion of unopsonized environmental particles such as TiO(2) and Fe(2)O(3) (1.3 microm in diameter). However, very little is known about the cellular uptake of nanoparticles. In the present study, we investigated whether MARCO mediates the uptake of nanoparticles by using fluorescent-tagged polystyrene particles (20 nm, 200 nm, and 1 microm in diameter). COS-7 cells were transfected with either MARCO cDNA or an empty vector, and the association of the particles with the cells were observed by fluorescence microscopy and atomic force microscopy. MARCO-transfected cells associated with all three sizes of particles in a time-dependent manner, while no obvious binding of particles occurred after 5 h to the empty vector-transfected cells. The uptake of particles by MARCO-transfected cells was partially inhibited by polyG. These results suggest that macrophages associate with nanoparticles (20 nm) at least in part through MARCO and that MARCO plays a role in clearing nanoparticles which can deposit in the alveolar region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361018     DOI: 10.1093/toxsci/kfm050

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  42 in total

1.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

2.  Macrophage responses to silica nanoparticles are highly conserved across particle sizes.

Authors:  Katrina M Waters; Lisa M Masiello; Richard C Zangar; Barbara J Tarasevich; Norman J Karin; Ryan D Quesenberry; Somnath Bandyopadhyay; Justin G Teeguarden; Joel G Pounds; Brian D Thrall
Journal:  Toxicol Sci       Date:  2008-12-10       Impact factor: 4.849

Review 3.  Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

Authors:  Suchitra Prasad; Dan Xu; Stephen D Miller
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Implications of scavenger receptors in the safe development of nanotherapeutics.

Authors:  Jonathan H Shannahan; Wei Bai; Jared M Brown
Journal:  Receptors Clin Investig       Date:  2015

5.  Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro.

Authors:  Angela França; Parag Aggarwal; Eugene V Barsov; Serguei V Kozlov; Marina A Dobrovolskaia; África González-Fernández
Journal:  Nanomedicine (Lond)       Date:  2011-06-15       Impact factor: 5.307

6.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

Review 7.  Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles.

Authors:  Ryan M Pearson; Joseph R Podojil; Lonnie D Shea; Nicholas J C King; Stephen D Miller; Daniel R Getts
Journal:  Nanomedicine       Date:  2018-10-21       Impact factor: 5.307

8.  Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation.

Authors:  Christine A Vaine; Milan K Patel; Jintao Zhu; Eunji Lee; Robert W Finberg; Ryan C Hayward; Evelyn A Kurt-Jones
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

9.  Barrier capacity of human placenta for nanosized materials.

Authors:  Peter Wick; Antoine Malek; Pius Manser; Danielle Meili; Xenia Maeder-Althaus; Liliane Diener; Pierre-Andre Diener; Andreas Zisch; Harald F Krug; Ursula von Mandach
Journal:  Environ Health Perspect       Date:  2009-11-12       Impact factor: 9.031

10.  Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytes.

Authors:  Christiane Eder; Marion Frankenberger; Franz Stanzel; Albrecht Seidel; Karl-Werner Schramm; Loems Ziegler-Heitbrock; Thomas Pj Hofer
Journal:  Part Fibre Toxicol       Date:  2009-10-16       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.